Assessment of In Vivo Clinical Product Performance of a Weak Basic Drug by Integration of In Vitro Dissolution Tests and Physiologically Based Absorption Modeling
Autor: | Xuan Ding, Carrie A. Coutant, Ivelina Gueorguieva, Lee J. Burns, James A. Wesley |
---|---|
Rok vydání: | 2015 |
Předmět: |
Absorption (pharmacology)
Adult Male Materials science Pharmaceutical Science Administration Oral Pharmacology Models Biological Permeability In vivo Galunisertib Animals Humans Dissolution testing Dissolution Supersaturation Middle Aged Rats Inbred F344 Rats Biopharmaceutical Intestinal Absorption Solubility Z-factor Quinolines Pyrazoles Female Biochemical engineering Research Article |
Zdroj: | The AAPS journal. 17(6) |
ISSN: | 1550-7416 |
Popis: | Effective integration of in vitro tests and absorption modeling can greatly improve our capability in understanding, comparing, and predicting in vivo performances of clinical drug products. In this case, we used a proprietary drug candidate galunisertib to describe the procedures of designing key in vitro tests, analyzing relevant experimental and trial data, and integrating them into physiologically based absorption models to evaluate the performances of its clinical products. By simulating the preclinical study result, we estimated high in vivo permeability for the drug. Given the high sensitivity of its solubility to pH, supersaturation may play an important role in the absorption of galunisertib. Using the dynamic dissolution test, i.e., artificial stomach-duodenum (ASD) model and simulation, we concluded galunisertib in solution or tablet products could maintain supersaturation during the transit in the gastrointestinal tract (GIT). A physiologically based absorption model was established by incorporating these key inputs in the simulation of Trial 1 results of galunisertib solution. To predict the performance of three tablet products, we developed z-factor dissolution models from the multi-pH USP dissolution results and integrate them into the absorption model. The resultant biopharmaceutical models provided good prediction of the extent of absorption of all three products, but underestimated the rate of absorption of one tablet product. Leveraging the ASD result and optimization with the dissolution model, we identified the limitation of the model due to complexity of estimating the dissolution parameter z and its in vitro-in vivo correlation. |
Databáze: | OpenAIRE |
Externí odkaz: |